Phân Tích Cắt Ngang Về Sử Dụng Thuốc Lá Và Việc Sử Dụng Đồng Thời Rượu Và Chất Kích Thích Ở Những Bệnh Nhân Sống Chung Với Nhiễm HIV/HCV: Kết Quả Từ Một Trung Tâm Tầng Ba Lớn Ở Đô Thị

Arnson, Y., Shoenfeld, Y., & Amital, H. (2010). Effects of tobacco smoke on immunity, inflammation and autoimmunity. Journal of Autoimmunity, 34, J258–J265. https://doi.org/10.1016/j.jaut.2009.12.003. Barrett, S. P., Darredeau, C., & Pihl, R. O. (2006). Patterns of simultaneous polysubstance use in drug using university students. Human Psychopharmacology, 21, 255–263. https://doi.org/10.1002/hup.766. Bean, M. C., Richey, L. E., Williams, K., Wahlquist, A. E., & Kilby, J. M. (2016). Tobacco Use patterns in a Southern US HIV clinic. Southern Medical Journal, 109, 305–308. https://doi.org/10.14423/SMJ.0000000000000460. Berlin, I., Thomas, D., Le Faou, A.-L., & Cornuz, J. (2020). COVID-19 and smoking. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntaa059. Bhatta, D. N., Subedi, A., & Sharma, N. (2018). Tobacco smoking and alcohol drinking among HIV infected people using antiretroviral therapy. Tobacco Induced Diseases, 16, 16. https://doi.org/10.18332/tid/86716. Bosh, K. A., Coyle, J. R., Hansen, V., Kim, E. M., Speers, S., Comer, M., …, Hall, H. I. (2018). HIV and viral hepatitis coinfection analysis using surveillance data from 15 US states and two cities. Epidemiology and Infection, 146, 920–930. https://doi.org/10.1017/S0950268818000766 Bradley, K. A., McDonell, M. B., Bush, K., Kivlahan, D. R., Diehr, P., & Fihn, S. D. (1998). The AUDIT alcohol consumption questions: Reliability, validity, and responsiveness to change in older male primary care patients. Alcoholism, Clinical and Experimental Research, 22, 1842–1849. Bush, K., Kivlahan, D. R., McDonell, M. B., Fihn, S. D., & Bradley, K. A. (1998). The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Ambulatory care quality improvement project (ACQUIP). Alcohol Use Disorders Identification Test. Archives of Internal Medicine, 158, 1789–1795. Calvo-Sanchez, M., & Martinez, E. (2015). How to Address smoking cessation in HIV patients. HIV Medicine. https://doi.org/10.1111/HIV.12193. Calvo, M., Laguno, M., Martínez, M., & Martínez, E. (2015). Effects of tobacco smoking on HIV-infected individuals. AIDS Reviews, 17, 47–55. Cohn, A. M., Johnson, A. L., Rose, S. W., Pearson, J. L., Villanti, A. C., & Stanton, C. (2018). Population-level patterns and mental health and substance use correlates of alcohol, marijuana, and tobacco use and co-use in US young adults and adults: Results from the population assessment for tobacco and health. The American Journal on Addictions, 27, 491–500. https://doi.org/10.1111/ajad.12766. Creamer, M. R., Wang, T. W., Babb, S., Cullen, K. A., Day, H., Willis, G., …, Neff, L. (2019). Tobacco product use and cessation indicators among adults—United States, 2018. MMWR Morbidity and Mortality Weekly Report, 68, 1013–1019https://doi.org/10.15585/mmwr.mm6845a2 Cropsey, K. L., Willig, J. H., Mugavero, M. J., Crane, H. M., McCullumsmith, C., Lawrence, S., …, CFAR Network of Integrated Clinical Systems. (2016). Cigarette smokers are less likely to have undetectable viral loads: Results from four HIV clinics. Journal of Addiction Medicine, 10, 13–19https://doi.org/10.1097/ADM.0000000000000172 Easterbrook, P., Sands, A., & Harmanci, H. (2012). Challenges and priorities in the management of HIV/HBV and HIV/HCV coinfection in resource-limited settings. Seminar of Liver Disease, 2012, 147–157. Emami, A., Javanmardi, F., Pirbonyeh, N., & Akbari, A. (2020). Prevalence of underlying diseases in hospitalized patients with COVID-19: A systematic review and meta-analysis. Archives of Academic Emergency Medicine, 24, e35–e49. Feldman, C., & Anderson, R. (2013). Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems. Journal of Infection, 67, 169–184. https://doi.org/10.1016/j.jinf.2013.05.004. Felsenstein, S., Herbert, J., McNamara, P., & Hedrich, C. (2020). COVID-19: Immunology and treatment options. Clinical Immunology (Orlando, Fla.). https://doi.org/10.1016/J.CLIM.2020.108448. Gartner, C., Miller, A., & Bonevski, B. (2017). Extending survival for people with hepatitis C using tobacco dependence treatment. Lancet (London, England), 390, 2033. https://doi.org/10.1016/S0140-6736(17)32460-1. Gritz, E. R., Danysh, H. E., Fletcher, F. E., Tami-Maury, I., Fingeret, M. C., King, R. M., …, Vidrine, D. J. (2013). Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV/AIDS. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 57, 608–615https://doi.org/10.1093/cid/cit349 Helleberg, M., Afzal, S., Kronborg, G., Larsen, C. S., Pedersen, G., Pedersen, C., …, Obel, N. (2013). Mortality attributable to smoking among HIV-1-infected individuals: A nationwide, population-based cohort study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 56, 727–734https://doi.org/10.1093/cid/cis933 Hézode, C., Lonjon, I., Roudot-Thoraval, F., Mavier, J.-P., Pawlotsky, J.-M., Zafrani, E. S., et al. (2003). Impact of smoking on histological liver lesions in chronic hepatitis C. Gut, 52, 126–129. https://doi.org/10.1136/gut.52.1.126. Huang, X., Wei, F., Hu, L., Wen, L., & Chen, K. (2020). Epidemiology and clinical characteristics of COVID-19. Archives of Iranian Medicine. https://doi.org/10.34172/AIM.2020.09. Humfleet, G. L., Delucchi, K., Kelley, K., Hall, S. M., Dilley, J., & Harrison, G. (2009). Characteristics of HIV-positive cigarette smokers: A sample of smokers facing multiple challenges. AIDS Education and Prevention: Official Publication of the International Society for AIDS Education, 21, 54–64. https://doi.org/10.1521/aeap.2009.21.3_supp.54. Jha, P., Ramasundarahettige, C., Landsman, V., Rostron, B., Thun, M., Anderson, R. N., …, Peto, R. (2013). 21st-century hazards of smoking and benefits of cessation in the United States. The New England Journal of Medicine, 368, 341–350https://doi.org/10.1056/NEJMsa1211128 Jiang, H., Zhou, Y., & Tang, W. (2020). Maintaining HIV care during the COVID-19 pandemic. The Lancet HIV, 20, S2352–3018. https://doi.org/10.1016/S2352-3018(20)30105-3. Keith, A., Dong, Y., Shuter, J., & Himelhoch, S. (2016). Behavioral interventions for tobacco use in HIV-infected smokers: A meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 1999(72), 527–533. https://doi.org/10.1097/QAI.0000000000001007. Kim, R. S., Weinberger, A. H., Chander, G., Sulkowski, M. S., Norton, B., & Shuter, J. (2018). Cigarette smoking in persons living with hepatitis C: The national health and nutrition examination survey (NHANES), 1999–2014. The American Journal of Medicine, 131, 669–675. https://doi.org/10.1016/j.amjmed.2018.01.011. Konopnicki, D., Mocroft, A., de Wit, S., Antunes, F., Ledergerber, B., Katlama, C., …, EuroSIDA Group. (2005). Hepatitis B and HIV: Prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS (London, England), 19, 593–601 Koziel, M. J., & Peters, M. G. (2007). Viral hepatitis in HIV infection. The New England Journal of Medicine, 356, 1445–1454. https://doi.org/10.1056/NEJMra065142. Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16, 606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x. Lim, J. K., Tate, J. P., Fultz, S. L., Goulet, J. L., Conigliaro, J., Bryant, K. J., …, Lo Re, V. (2014). Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 58, 1449–1458https://doi.org/10.1093/cid/ciu097 Massa, A., & Rosen, M. (2012). The relationship between substance use and HIV transmission in Peru. Journal of Addiction Research & Therapy. https://doi.org/10.4172/2155-6105.1000129. Mercie, P., Arsandaux, J., Katlama, C., Ferret, S., Beuscart, A., Spadone, C., …, Group, A. 144 I.-A. S. (2018). Efficacy and Safety of Varenicline for Smoking Cessation in People Living With HIV in France (ANRS 144 Inter-ACTIV): A Randomised Controlled Phase 3 Clinical Trial. The Lancet HIV, 5, e126–e135https://doi.org/10.1016/S2352-3018(18)30002-X Nahvi, S., & Cooperman, N. A. (2009). Review: The need for smoking cessation among HIV-positive smokers. AIDS Education and Prevention: Official Publication of the International Society for AIDS Education, 21, 14–27. https://doi.org/10.1521/aeap.2009.21.3_supp.14. National Center for Chronic Disease Prevention and Health Promotion (US). (2010). How tobacco smoke causes disease: The biology and behavioral basis for smoking-attributable disease: A report of the surgeon general. Retrieved February 15, 2020, from https://www.ncbi.nlm.nih.gov/pubmed/21452462 National Center for Chronic Disease Prevention and Health Promotion (US). (2014). The Health consequences of smoking—50 years of progress: A report of the surgeon general. Retrieved February 15, 2020, from https://www.ncbi.nlm.nih.gov/pubmed/24455788 National Institutes of Health. (2019). Patient-reported outcomes measurement information system (PROMIS). Retrieved February 2, 2020, from https://commonfund.nih.gov/promis/index Newcombe, D., Humeniuk, R., & Ali, R. (2005). Validation of the World Health Organization alcohol, smoking and substance involvement screening test (ASSIST): Report of results from the Australian site. Drug and Alcohol Review, 24, 217–226. https://doi.org/10.1080/09595230500170266. Pessione, F., Ramond, M. J., Njapoum, C., Duchatelle, V., Degott, C., Erlinger, S., …, Degos, F. (2001). Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology (Baltimore, Md.), 34, 121–125https://doi.org/10.1053/jhep.2001.25385 Petrosillo, N., & Cicalini, S. (2013). Smoking and HIV: Time for a change? BMC Medicine, 11, 16. https://doi.org/10.1186/1741-7015-11-16. Pool, E. R. M., Dogar, O., Lindsay, R. P., Weatherburn, P., & Siddiqi, K. (2016). Interventions for tobacco use cessation in people living with HIV and AIDS. The Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD011120.pub2. Promotion, O. of D. P. and H. (2020). Healthy People. Retrieved April 30, 2020, from https://www.healthypeople.gov/2020/About-Healthy-People Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33, 337–343. Rahmanian, S., Wewers, M. E., Koletar, S., Reynolds, N., Ferketich, A., & Diaz, P. (2011). Cigarette smoking in the HIV-infected population. Proceedings of the American Thoracic Society, 8, 313–319. https://doi.org/10.1513/pats.201009-058WR. Re, V. L., Kallan, M. J., Tate, J. P., Localio, A. R., Lim, J. K., Goetz, M. B., …, Justice, A. C. (2014). Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus–monoinfected patients. Annals of Internal Medicine, 160, 369–379https://doi.org/10.7326/M13-1829 Shuter, J., Kim, R. S., An, L. C., & Abroms, L. C. (2018). Feasibility of a smartphone-based tobacco treatment for HIV-infected smokers. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco. https://doi.org/10.1093/ntr/nty208. Shuter, J., Litwin, A. H., Sulkowski, M. S., Feinstein, A., Bursky-Tammam, A., Maslak, S., …, Norton, B. (2016). Cigarette smoking behaviors and beliefs in persons living with hepatitis C. Nicotine & Tobacco Research, 19, ntw212https://doi.org/10.1093/ntr/ntw212 Sims, O. T., Chiu, C.-Y., Chandler, R., Melton, P., Wang, K., Richey, C., et al. (2019). Alcohol use and ethnicity independently predict antiretroviral therapy nonadherence among patients living with HIV/HCV coinfection. Journal of Racial and Ethnic Health Disparities. https://doi.org/10.1007/s40615-019-00630-8. Sims, O. T., Melton, P. A., & Ji, S. (2018). A descriptive analysis of a community clinic providing hepatitis C treatment to poor and uninsured patients. Journal of Community Health. https://doi.org/10.1007/s10900-018-0476-2. Steel, H. C., Venter, W. D. F., Theron, A. J., Anderson, R., Feldman, C., Kwofie, L., …, Rossouw, T. M. (2018). Effects of tobacco usage and antiretroviral therapy on biomarkers of systemic immune activation in HIV-infected participants. Mediators of Inflammation, 2018, 8357109https://doi.org/10.1155/2018/8357109 Strzelak, A., Ratajczak, A., Adamiec, A., & Feleszko, W. (2018). Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: A mechanistic review. International Journal of Environmental Research and Public Health, 15, 1033. https://doi.org/10.3390/ijerph15051033. Szabo, G., Wands, J. R., Eken, A., Osna, N. A., Weinman, S. A., Machida, K., et al. (2010). Alcohol and hepatitis C virus–interactions in immune dysfunctions and liver damage. Alcoholism, Clinical and Experimental Research, 34, 1675–1686. https://doi.org/10.1111/j.1530-0277.2010.01255.x. Taylor, L. E., Swan, T., & Mayer, K. H. (2012). HIV coinfection with hepatitis C virus: Evolving epidemiology and treatment paradigms. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 55, S33–42. https://doi.org/10.1093/cid/cis367. Teira, R. (2013). Hepatitis-B virus infection predicts mortality of HIV and hepatitis C virus coinfected patients. AIDS, 27, 845–848. https://doi.org/10.1097/QAD.0b013e32835ecaf7. Tesoriero, J. M., Gieryic, S. M., Carrascal, A., & Lavigne, H. E. (2010). Smoking among HIV positive New Yorkers: Prevalence, frequency, and opportunities for cessation. AIDS and Behavior, 14, 824–835. https://doi.org/10.1007/s10461-008-9449-2. Thein, H.-H., Yi, Q., Dore, G. J., & Krahn, M. D. (2008). Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS (London, England), 22, 1979–1991. https://doi.org/10.1097/QAD.0b013e32830e6d51. Triant, V. A., Grossman, E., Rigotti, N. A., Ramachandran, R., Regan, S., Sherman, S. E., …, Harrington, K. F. (2019). Impact of smoking cessation interventions initiated during hospitalization among HIV-infected smokers. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobaccohttps://doi.org/10.1093/ntr/ntz168 U.S. Department of Health & Human Services. (2015). Calculating the U.S. Populatoin-based EQ-5D Index Score. Retrieved March 17, 2018, from https://archive.ahrq.gov/professionals/clinicians-providers/resources/rice/EQ5Dscore.html Vidrine, D. J., Marks, R. M., Arduino, R. C., & Gritz, E. R. (2012). Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco, 14, 106–110. https://doi.org/10.1093/ntr/ntr121. Zhao, L., Li, F., & Taylor, E. W. (2013). Can tobacco use promote HCV-induced miR-122 hijacking and hepatocarcinogenesis? Medical Hypotheses, 80, 131–133. https://doi.org/10.1016/j.mehy.2012.11.009. Zhao, Q., Meng, M., Kumar, R., Wu, Y., Huang, J., Lian, N., …, Lin, S. (2020). The impact of COPD and smoking history on the severity of Covid-19: A systemic review and meta-analysis. Journal of Medical Virology. https://doi.org/10.1002/JMV.25889